Literature DB >> 22560631

Structural characterization of surface glycans from Clostridium difficile.

Christopher W Reid1, Evgeny Vinogradov, Jianjun Li, Harold C Jarrell, Susan M Logan, Jean-Robert Brisson.   

Abstract

Whole-cell high-resolution magic angle spinning (HR-MAS) NMR was employed to survey the surface polysaccharides of a group of clinical and environmental isolates of Clostridium difficile. Results indicated that a highly conserved surface polysaccharide profile among all strains studied. Multiple additional peaks in the anomeric region were also observed which prompted further investigation. Structural characterization of the isolated surface polysaccharides from two strains confirmed the presence of the conserved water soluble polysaccharide originally described by Ganeshapillai et al. which was composed of a hexaglycosyl phosphate repeat consisting of [→6)-β-D-Glcp-(1-3)-β-D-GalpNAc-(1-4)-α-D-Glcp-(1-4)-[β-D-Glcp(1-3]-β-D-GalpNAc-(1-3)-α-D-Manp-(1-P→]. In addition, analysis of phenol soluble polysaccharides revealed a similarly conserved lipoteichoic acid (LTA) which could be detected on whole cells by HR-MAS NMR. Conventional NMR and mass spectrometry analysis indicated that the structure of this LTA consisted of the repeat unit [→6)-α-D-GlcpNAc-(1-3)-[→P-6]-α-D-GlcpNAc-(1-2)-D-GroA] where GroA is glyceric acid. The repeating units were linked by a phosphodiester bridge between C-6 of the two GlcNAc residues (6-P-6). A minor component consisted of GlcpN-(1-3) instead of GlcpNAc-(1-3) in the repeat unit. Through a 6-6 phosphodiester bridge this polymer was linked to →6)-β-D-Glcp-(1-6)-β-D-Glcp-(1-6)-β-D-Glcp-(1-1)-Gro, with glycerol (Gro) substituted by fatty acids. This is the first report of the utility of HR-MAS NMR in the examination of surface carbohydrates of Gram positive bacteria and identification of a novel LTA structure from Clostridium difficile. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560631     DOI: 10.1016/j.carres.2012.02.002

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  21 in total

1.  Structure of the LPS O-chain from Fusobacterium nucleatum strain 10953, containing sialic acid.

Authors:  Evgeny Vinogradov; Frank St Michael; Kiyonobu Homma; Ashu Sharma; Andrew D Cox
Journal:  Carbohydr Res       Date:  2017-01-28       Impact factor: 2.104

Review 2.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

Review 3.  Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria.

Authors:  Olaf Schneewind; Dominique Missiakas
Journal:  J Bacteriol       Date:  2014-01-10       Impact factor: 3.490

4.  The Ser/Thr Kinase PrkC Participates in Cell Wall Homeostasis and Antimicrobial Resistance in Clostridium difficile.

Authors:  Elodie Cuenot; Transito Garcia-Garcia; Thibaut Douche; Olivier Gorgette; Pascal Courtin; Sandrine Denis-Quanquin; Sandra Hoys; Yannick D N Tremblay; Mariette Matondo; Marie-Pierre Chapot-Chartier; Claire Janoir; Bruno Dupuy; Thomas Candela; Isabelle Martin-Verstraete
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria.

Authors:  Stefan G Richter; Derek Elli; Hwan Keun Kim; Antoni P A Hendrickx; Joseph A Sorg; Olaf Schneewind; Dominique Missiakas
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.

Authors:  Andrew D Cox; Frank St Michael; Annie Aubry; Chantelle M Cairns; Philippa C R Strong; Alexander C Hayes; Susan M Logan
Journal:  Glycoconj J       Date:  2013-08-23       Impact factor: 2.916

7.  Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.

Authors:  Maria R Romano; Rosanna Leuzzi; Emilia Cappelletti; Marta Tontini; Alberto Nilo; Daniela Proietti; Francesco Berti; Paolo Costantino; Roberto Adamo; Maria Scarselli
Journal:  Toxins (Basel)       Date:  2014-04-22       Impact factor: 4.546

Review 8.  An update on antibody-based immunotherapies for Clostridium difficile infection.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Clin Exp Gastroenterol       Date:  2016-08-01

9.  Lysozyme Resistance in Clostridioides difficile Is Dependent on Two Peptidoglycan Deacetylases.

Authors:  Gabriela M Kaus; Lindsey F Snyder; Ute Müh; Matthew J Flores; David L Popham; Craig D Ellermeier
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.476

10.  Clostridium difficile surface proteins are anchored to the cell wall using CWB2 motifs that recognise the anionic polymer PSII.

Authors:  Stephanie E Willing; Thomas Candela; Helen Alexandra Shaw; Zoe Seager; Stéphane Mesnage; Robert P Fagan; Neil F Fairweather
Journal:  Mol Microbiol       Date:  2015-03-06       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.